Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Johnson & Johnson

Johnson & Johnson
1886 FOUNDED
PUBLIC STATUS
>100K EMPLOYEES
JNJ STOCK SYMBOL
122 INVESTMENTS
$139.79 SHARE PRICE (As of Thursday Closing)
Description

Johnson & Johnson is the world's largest and most diverse healthcare company. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, close to half of total revenue is generated in the United States.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Personal Products
Conglomerates
Stock Exchange
NYS
Primary Office
  • One Johnson & Johnson Plaza
  • New Brunswick, NJ 08933
  • United States

+1 (732) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Johnson & Johnson’s full profile, request a free trial.

Johnson & Johnson Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$118.62 - $148.99 $371B $138.76 $5.48 6.19M 2.66B

Johnson & Johnson Financials Summary

In Thousands,
USD
TTM
31-Mar-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 383,021,915 362,394,257 360,579,581 294,917,460
Revenue 81,593,000 81,581,000 76,450,000 71,890,000
EBITDA 24,136,000 25,322,000 23,864,000 23,915,000
Net Income 14,679,000 15,297,000 1,300,000 16,540,000
Total Assets 150,027,000 152,954,000 157,303,000 141,208,000
Total Debt 29,368,000 30,480,000 34,581,000 27,126,000
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Johnson & Johnson Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Johnson & Johnson‘s full profile, request access.

Request full access to PitchBook

Johnson & Johnson Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pfizer Corporate Backed or Acquired New York, NY 00000 000000000000
000000000 Private Equity-Backed Montreal, Canada 000 000.00 000000000000
To view this company’s complete list of competitors, request access »

Johnson & Johnson Investments & Acquisitions (122)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 01-Apr-2019 000000000 Other Healthcare Technology Systems
00000000 01-Mar-2019 0000 00000 Biotechnology
00000 13-Feb-2019 000000000000000000 00.000 Surgical Devices 000000 000000
00:0 00000000 17-Jan-2019 000000000000000000 00.000 Personal Products 00000 00000000
XVision 01-Nov-2018 Grant 00.000 Other Healthcare
To view this company’s complete investment and acquisition history, request access »

Johnson & Johnson Exits (32)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 0000000 12-Mar-2012 000000 Completed
  • 5 buyers
0000000000 11-Jan-2012 00000 00000 00 Completed
  • 0000000 & 0000000
000000000 00000000 03-Jan-2009 00000 00.000 Completed
  • 9 buyers
000000000 21-Dec-2005 000000000 00000 00 Completed
  • 0000000 & 0000000
Light Sciences Oncology 14-Dec-2005 Later Stage VC 0000 Completed
  • 8 buyers
To view this company’s complete exits history, request access »

Johnson & Johnson Subsidiaries (28)

Company Name Industry Location Founded
Emerging Implant Technologies Surgical Devices Tuttlingen, Germany 2014
000 0000000 & 0000 Corporate Pension Cork, Ireland 0000
000000'0 00000000 Pharmaceuticals South Jordan, UT 0000
00000 Surgical Devices Redwood City, CA 0000
00000 000000000 Biotechnology South San Francisco, CA 0000
To view this company’s complete subsidiary history, request access »

Johnson & Johnson Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Johnson & Johnson‘s full profile, request access.

Request full access to PitchBook

Johnson & Johnson Executive Team (172)

Name Title Board
Seat
Contact
Info
Alex Gorsky Chairman & Chief Executive Officer
Peter Soderberg President
Xie Jian President, Johnson & Johnson Medical China
Catherine Devine President, OTC franchise
Joseph Wolk Chief Financial Officer & Executive Vice President

23 Former Executives

You’re viewing 5 of 172 executives. Get the full list »

Johnson & Johnson Board Members (15)

Name Representing Role Since Contact
Info
0000 000000 Johnson & Johnson Chairman & Chief Executive Officer 000 0000
000000 000000 Johnson & Johnson Group Chairman, Johnson & Johnson Vision and Diabetes Care 000 0000
000 00000 Self Board Member 000 0000
0000000 00000 Self Vice Chairman 000 0000
00000 00000000 Johnson & Johnson Chairman 000 0000

5 Former Board Members

You’re viewing 5 of 15 board members. Get the full list »